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Abstract
Background: In patients with COPD, both laboratory exercise tests and field walking tests are
used to assess physical performance. In laboratory tests, peak exercise capacity in watts (W peak)
and/or peak oxygen uptake (VO2 peak) are assessed, whereas the performance on walking tests
usually is expressed as distance walked. The aim of the study was to investigate the relationship
between an incremental shuttle walking test (ISWT) and two laboratory cycle tests in order to
assess whether W peak could be estimated from an ISWT.
Methods: Ninety-three patients with moderate or severe COPD performed an ISWT, an
incremental cycle test (ICT) to measure W peak and a semi-steady-state cycle test with breath-by-
breath gas exchange analysis (CPET) to measure VO2 peak. Routine equations for conversion
between cycle tests were used to estimate W peak from measured VO2 peak (CPET). Conversion
equation for estimation of W peak from ISWT was found by univariate regression.
Results: There was a significant correlation between W peak and distance walked on ISWT × body
weight (r = 0.88, p < 0.0001). The agreement between W peak measured by ICT and estimated
from ISWT was similar to the agreement between measured W peak (ICT) and W peak estimated
from measured VO2 peak by CPET.
Conclusion: Peak exercise capacity measured by an incremental cycle test could be estimated
from an ISWT with similar accuracy as when estimated from peak oxygen uptake in patients with
COPD.
Background
Measurements of exercise capacity are important and
widely used in rehabilitation of patients with chronic
obstructive pulmonary disease (COPD). Exercise testing
in COPD varies from maximal laboratory tests, requiring
advanced technical equipment, to simple field tests. Max-
imal laboratory tests are mostly constructed to measure
peak exercise capacity (W peak), and/or peak oxygen
uptake (VO2 peak) whereas field tests have been consid-
ered to reflect functional capacity [1-3]. The incremental
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to the laboratory tests as it is externally paced and progres-
sive [4]. During ISWT there is a linear relationship
between VO2 and walking speed, similar to the relation-
ship between VO2 and work rate in incremental labora-
tory testing [5,6]. Singh et al found, when comparing
incremental laboratory treadmill test and ISWT, that VO2
peak could be estimated from distance walked on ISWT
[5].
Singh et al compared two different walking tests (tread-
mill and ISWT) and it is unclear whether such a strong
relationship would also be found between ISWT and cycle
performance. In laboratory testing, the treadmill test
evokes slightly higher ratings of VO2 peak than the cycle
tests [7,8], whereas different protocols of cycle tests usu-
ally result in similar VO2 peak but different W peak,
depending on the slope of increased load during the test
[9-11]. Body weight is an important contributor to the
work load during walking, whereas it is of minor impor-
tance during cycling. Thus, the correlation between per-
formance on timed walking tests and VO2 peak from a
cycle test becomes stronger if distance walked is multi-
plied by body weight (distance × weight = work of walking
at horizontal level) [12,13]. Recent findings indicate that
metabolic and ventilatory responses to walking may differ
from the responses to cycling in patients with COPD
[8,14,15]. In pulmonary rehabilitation many exercise pro-
grammes are conducted on ergometer cycles. Target train-
ing intensity is often expressed as a percent of W peak,
which in turn usually is defined as the highest work rate
tolerated during an incremental cycle test with 1-minute
steps or ramp increments. From a known VO2 peak it is
possible to estimate W peak [16,17], and as VO2 peak can
be estimated from an ISWT [5] it seems reasonable to
assume that W peak could be estimated from ISWT
through the estimated VO2 peak. However, using two con-
version equations would make the results less reliable.
Therefore, an estimation of W peak directly from the per-
formance on ISWT would be preferable. This would be of
clinical interest when expensive laboratory tests are not
available.
The aim of the present study was to investigate whether W
peak (assessed on a cycle ergometer) could be estimated
from an ISWT in patients with moderate or severe COPD.
For this purpose, comparisons of ISWT and two different
cycle tests were made.
Methods
Material
Ninety-three subjects with moderate or severe COPD
according to the British Thoracic Society [18] were consec-
utively invited to take part in the study when being
referred for training to the Physiotherapy Unit of the Pul-
monary Section at the Akademiska Hospital, Uppsala,
Sweden during 2001–2004. All were smokers or ex-smok-
ers. The study was approved by the Medical Ethics Com-
mittee of Uppsala University and all subjects gave
informed consent.
Inclusion criteria were COPD with forced expiratory vol-
ume in one second (FEV1) < 60% of predicted value and
FEV1/VC (vital capacity) < 0.7 after bronchodilatation
[18]. Exclusion criteria were other diseases interfering
with exercise such as ischemic coronary disease and mus-
culo-skeletal problems.
Testing
Lung function was measured with a Masterlab Trans
spirometer, Masterlab Body Plethysmograph and Master-
lab Transfer (Erich Jaeger AG, Würzburg, Germany) in
accordance with the ATS guidelines [19]. Swedish refer-
ence values were used [20,21].
Incremental shuttle walking test (ISWT) was performed in
a level corridor. Two cones were placed 9 m apart com-
prising a 10 m track as described by Singh et al [4].
Instructions to the subject and the pace of the test were
played from a tape recorder. The test commenced at a
speed of 30 m/min which then was increased by 10 m/
min every minute. The subjects continued walking until
they were not able to reach the next cone in time for the
signal or got too exhausted to continue. The total distance
walked was the main outcome of the test. Before and
directly after walking, oxygen saturation (SpO2), heart
rate, peak expiratory flow (PEF), perceived exertion (Borg
RPE-scale) [22] and dyspnoea (Borg CR-10-scale) [23]
were registered. The patients carried a pulse oximeter
(Optovent Respons, Optovent, Linköping, Sweden) by a
shoulder strap throughout the test. In 52 of the patients
the test was identically repeated within a week.
Symptom-limited incremental cycle ergometer test (ICT)
(Case 8000 Exercise Testing System, GE Medical Systems,
Milwaukee, USA) with continuous ECG-registration was
conducted to measure peak work load (W peak). The sub-
jects started pedalling at 20 W and the load was then
increased by 10 W every fulfilled minute until exhaustion.
Heart rate, breathing frequency and SpO2 (Optovent
Respons) were registered every minute during exercise.
Systolic blood pressure, subjective ratings of perceived
exertion and dyspnoea were recorded every other minute
[22,23]. All variables were measured before and 1, 2, 4
and 10 minutes after exercise.
A semi-steady-state cardiopulmonary exercise test with
breath-by-breath gas exchange analysis (CPET) was per-
formed, according to routines at our clinic, after resting
for at least 30 min after the incremental cycle test (longerPage 2 of 7
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cise levels). Measurements of heart rate, SpO2 and ratings
of perceived exertion and dyspnoea were made identically
to the incremental cycle test. To enable measurement of
VO2 peak, the subjects wore a mask with a turbine for gas
exchange analysis (Oxycon Sigma, Jaeger, Germany).
Additionally, VCO2(carbon dioxide), minute ventilation
(VE), respiratory quotient (RQ) and breathing frequency
were measured with readings every 30 seconds. After
recording steady-state measurements at rest (approxi-
mately 4 min of registration at rest) the patient started
pedalling at 20 W. The load was kept constant until the
ventilation and oxygen uptake reached a plateau, on aver-
age 3–4 min at each level, then the load was increased. To
keep testing time within reasonable limits the load was
increased until exhaustion by 5, 10, 20 or 30 W depending
on the outcome of the first test (ICT).
The reason for discontinuing the cycle tests and the ISWT
was stated at the end of each test.
The two different ergometer cycle tests were performed on
the same day, but the lung function test and the ISWT
were conducted on separate days. The three test days were
separated by 1–3 resting days.
Conversion equations
W peak was estimated from the measured VO2 peak on
CPET by an equation derived from Åstrand [16]: (VO2
peak × 1000-1- 0.1517) × 0.0134-1. The equation from
Singh et al for estimating VO2 from ISWT [5] was multi-
plied by body weight to express ml/min instead of ml/
min/kg: (4.19 + 0.025 × walking distance) × body weight.
Statistical analysis
Results were expressed as mean and standard deviation
(SD) or 95% confidence interval (CI). For simple correla-
tions Pearson's correlation coefficient was calculated.
ANOVA and Student's t-test were calculated for paired
comparisons, except for RPE and CR-10 scores where
Friedman's ANOVA and Wilcoxon's signed rank test were
used. Scatterplots as recommended by Bland and Altman
were made for comparison of estimated and measured
values. The level of significance was set at 5%.
Results
All 93 subjects accepted to participate and were enrolled
in the study, 71 with severe disease according to the Brit-
ish Thoracic Society guidelines [18]. There were no drop-
outs. See Table 1 for characteristics.
Test results
Distance walked on ISWT was 314 (291–336) m. End-
exercise work load was 62 (57–68) W on the incremental
cycle test (i.e. W peak) and 46 (41–50) W on the CPET.
Measured peak VO2 on CPET was 973 (908–1038) ml/
min. There was significantly lower peak heart rate, SpO2,
ratings of perceived exertion and dyspnoea at the end of
the walking test compared to the cycle tests (Table 2). The
reported reasons for cessation were identical in the two
cycle tests: 39% because of dyspnoea, 35% because of a
combination of dyspnoea and exertion, 20% because of
exertion and 6% because of leg fatigue. In the ISWT the
reason for cessation was dyspnoea in 3%, a combination
of dyspnoea and exertion in 12% and inability to increase
or keep up the speed to reach the next cone in time in 85%
of the cases.
Fifty-two subjects repeated the ISWT within a week. The
difference between the two tests was not significant for
Table 1: Characteristics of the patients. Values expressed as 
mean ± SD and (range), n = 93.
Gender, male/female 26/67
Smoking habits, current/ex 23/70
Age, years 64 ± 7 (43–80)
Weight, kg 65.4 ± 13.2 (42–101)
BMI, kg/m2 23.4 ± 4.3 (14.5–34.9)
Packyears 36 ± 21 (8–120)
VC, liters 2.6 ± 0.9 (1.3–6.1)
VC, % predicted 67 ± 16 (40–121)
FEV1, liters 0.9 ± 0.3 (0.4–1.7)
FEV1, % predicted 32 ± 11 (14–59)
MVV, liters/min 33.5 ± 12.7 (15.0–66.7)
MVV, % predicted 46 ± 12 (16–83)
DLCO, µmol/sec/kPa 57.2 ± 22.4 (16.2–127)
DLCO, % predicted 50 ± 18 (15–106)
BMI: body mass index; VC: vital capacity; FEV1: forced expiratory 
volume in one second; MVV: maximum voluntary ventilation; DLCO: 
carbon monoxide diffusion capacity.
Table 2: End-exercise values from the three tests: ISWT, ICT and CPET, n = 93.
ISWT ICT CPET
SpO2, % 87*** (86–88) 90 (89–91) 89† (88–91)
Heart rate, beats/min 115*** (111–118) 131 (127–138) 131 (124–134)
Perceived exertion, RPE 15.9*** (15.5–16.3) 17.4 (17.1–17.6) 17.5 (17.2–17.7)
Dyspnoea, CR-10 6.2*** (5.8–6.6) 7.9 (7.6–8.3) 8.0 (7.7–8.4)
ISWT: incremental shuttle walking test, ICT: incremental cycle test, CPET: semi steady-state cardiopulmonary exercise test, SpO2: oxygen 
saturation in blood measured by pulsoximeter, RPE: Borg scale for ratings of perceived exertion, CR-10: Borg scale for dyspnoea, VO2 peak: peak 
oxygen uptake, ***: p < 0.0001 compared to ICT and CPET, †: p < 0.05 compared to ICT. Mean (95% CI).Page 3 of 7
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tance being 9 ± 38 m or 3% ± 12% (p = 0.09). All calcula-
tions were therefore based on the first ISWT. This
subgroup did not differ from the larger group in any base-
line characteristics.
Correlations and estimated W peak
There was a significant correlation (r = 0.88, p < 0.0001)
between ISWT distance × body weight and the measured
W peak from the incremental cycle test: W peak = 0.0025
× distance (m) × body weight (kg) + 10.19 (Fig. 1). W
peak estimated from performance on ISWT by this equa-
tion was 62 (57–66) W and did not differ significantly
from the measured W peak (62 (57–68) W, p = 0.7). For
comparison, W peak was estimated from the measured
VO2 peak by the equation derived from Åstrand [16],
resulting in an estimated W peak of 61 (56–66) W. This
was not significantly different from the measured W peak
or the estimated W peak from ISWT above. A strong agree-
ment was found between the measured and estimated val-
ues of W peak with a minor tendency to overestimation at
the lower range and underestimation at the higher range
of performance both when estimated from ISWT and
from VO2 peak (Fig. 2). There is one outlier where ISWT
clearly underestimated W peak (Fig. 2). This was the only
subject who would have been able to run at the end of the
ISWT, which, however, is not allowed in a walk test.
No significant differences were found between women
and men regarding the relationship between the different
exercise tests.
Comparisons with estimation based on previous findings
To test whether W peak could be estimated by use of the
equation by Singh et al [5], we estimated VO2 peak from
their equation and then converted this estimated VO2 to
The correlation between the peak exercise capacity (W peak) measured by an incremental cycle ergometer test and the dis-tance walked (m) on an incr m ntal shuttl walking test (ISWT) multiplied by body weight (kg)Figure 1
The correlation between the peak exercise capacity (W peak) measured by an incremental cycle ergometer test and the dis-
tance walked (m) on an incremental shuttle walking test (ISWT) multiplied by body weight (kg). Regression line and 95% confi-
dence bands. n = 93
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Singh et al, VO2 peak was underestimated compared to
our measurements (-171 ± 58 ml/min or -16 ± 15 %, p <
0.0001) which consequently resulted in an underestima-
tion of W peak (-14 ± 13 W, p < 0.0001).
Discussion
In the present study, ISWT distance × body weight was a
good predictor of W peak measured by an incremental
cycle test in patients with moderate or severe COPD. The
fact that W peak estimated from ISWT was as accurate as
W peak estimated from VO2 is of clinical importance, as
the ISWT is much simpler and cheaper than a laboratory
cycle test.
Our results confirm the findings of others that there is an
excellent correlation between performance on ISWT and
laboratory testing [5,6,24]. Although the correlation in
our study between VO2 and distance walked was almost
identical with the findings of Singh et al [5], applying
their equation in our material resulted in a significant
underestimation. One likely explanation to this could be
the difference in the number of subjects, as in their study
19 subjects were included, compared to 93 subjects in the
current study. As Singh et al performed two ISWT, and
used the second test in their analysis, that might explain
some of the inconsistency between their equation and
ours, even though no significant improvement on retest-
ing was found in our material. The majority of patients in
the study by Singh et al were men while our study was
dominated by women. Gender did not significantly affect
the relationship between the different tests in our analysis,
but this might need further investigation, as only 26% of
our subjects were men. The fact that Singh et al compared
two walking tests whereas we compared walking and
cycling might also explain the difference to some extent,
as there is a known difference in metabolic adaptations
during walking and cycling [8,15]. However, as VO2 peak
measured on a treadmill test has been found to be higher
than [8] or equal to [25] VO2 peak measured on a cycle
test in patients with COPD, a regression equation derived
from a treadmill test could be expected to overestimate
VO2 peak on a cycle rather than the opposite.
All patients who were referred to pulmonary rehabilita-
tion and fulfilled the inclusion criteria during the time of
the study agreed to participate. Therefore, we conclude
that the study is representative of a COPD-population
Scatterplots (Bland-Altman)Figure 2
Scatterplots (Bland-Altman). On the left, the difference between measured maximum exercise capacity (W peak) meas-
ured by incremental cycle test (ICT) and estimated W peak from performance on incremental shuttle walking test (ISWT) 
against the mean values of those two. On the right, the difference between measured W peak from ICT and estimated W peak 
from measured maximum oxygen uptake on semi steady-state cardiopulmonary exercise test (CPET) [16] against the mean of 
those two. Whole line: mean difference, dotted lines: ± 2SD.
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wide range of lung function impairment and age of the
participants also enhances the relevance of our sample. In
Sweden, women have caught up with men in the preva-
lence of and mortality in COPD [26]. The majority of
women referred to pulmonary rehabilitation during the
time of the study is noticeable and we can only speculate
that this might indicate that women were either more
often offered referral to pulmonary rehabilitation by their
physicians or were more likely to accept such an offer than
the men.
Heart rate, RPE- and CR-10-scores were significantly lower
in ISWT than in the cycle tests. The cycle tests were mainly
limited by breathlessness and/or exertion whereas the
ISWT was, in most cases, limited by the incapability to
increase the speed of walking. During walking it is diffi-
cult to increase walking speed above a certain level. Some
treadmill test protocols are therefore constructed to
increase inclination rather than speed [27].
SpO2 decreased more by walking than cycling in the cur-
rent study, quite in line with previous findings [8,14,24].
It has been speculated that the positional differences
between walking and cycling could lead to less effective
breathing during walking and thus more desaturation
[15]. In spite of the above differences between walking
and cycling, our results demonstrated that in patients with
moderate to severe COPD it was possible to estimate cycle
performance from an ISWT quite as accurately as when
estimating performance from one laboratory cycle test to
the other. As equations work both ways, our findings also
make it possible to estimate distance walked (and thereby
walking speed) on ISWT from W peak. This could be use-
ful in clinics where laboratory cycle testing is routine prac-
tice but exercise training prescription is mainly walking.
As the outlier in our study illustrates, the ISWT can be
expected to mimic performance in a symptom-limited
cycle test only in subjects that reach their exercise limit by
brisk walk, i.e. are unable to run, as otherwise the subjects
would not be close to their peak capacity during the test.
Being able to run is, however, a very rare condition in
COPD-patients referred to rehabilitation, implying that
this does not undermine the use of ISWT in patients with
COPD.
We used the first ISWT (no training test) for our analyses.
Due to the patient's poor condition or because of time
constraints it is often not feasible to perform a training
test in clinical practice. Thus, it was clinically relevant to
present our calculations based on the first ISWT. This was
also supported by the finding that the walking distance
did not increase at the second test performed within a
week. Control calculations were done by using results
(not shown) from the second ISWT (n = 52) in our mate-
rial and no differences were found. Significant difference
in walking distance has previously been found on
repeated testing with ISWT in patients with COPD [4,28].
It is not clear why our results are inconsistent with previ-
ous studies regarding the repeatability of ISWT, but, as
noted above, the number of subjects and gender distribu-
tion is somewhat different from the other studies, and this
might affect the repeatability.
It could be argued that the cycle tests should have been
performed in random order. The present design was cho-
sen because it enabled us to adjust the progressive pattern
of the CPET to keep exercise time within reasonable limits
when W peak from the incremental cycle test was known.
Although all subjects rested between the tests, we can not
rule out the possibility that the order of the tests could
have influenced the results. However, as peak heart rate,
CR-10 scores and ratings of perceived exertion (RPE) were
almost identical in the two cycle tests, and W peak could
be estimated from VO2 peak as expected [16], we consider
this error as relatively small.
Being able to estimate W peak by ISWT for clinical pur-
poses does not make ISWT a perfect substitute for the
incremental cycle test or other forms of laboratory tests.
There is, of course, some variation between estimated and
measured peak values on an individual basis, but most
importantly the safety aspect of the laboratory tests is
beyond the ISWT. Therefore, for COPD patients consid-
ered at increased risk for cardiovascular hazards, patients
that have never had proper cardiologic assessment or
patients with uncertain diagnosis, laboratory tests must be
considered as the first choice. However, for COPD-
patients of minor risk of cardiovascular incidents, and
where laboratory tests are scarce, the ISWT could be used
as an alternative for estimating W peak.
Conclusion
Peak exercise capacity measured by an incremental cycle
test could be estimated from an ISWT with similar accu-
racy as when estimated from peak oxygen uptake.
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